Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;75(1):228-229.
doi: 10.1016/j.jhep.2021.04.005. Epub 2021 Apr 20.

Reply to: "Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients"

Manuel Rodríguez-Perálvarez  1 , Jordi Colmenero  2 , Magdalena Salcedo  3 ; Spanish Society of Liver Transplantation (SETH)
Affiliations
Comment

Reply to: "Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients"

Manuel Rodríguez-Perálvarez et al. J Hepatol. 2021 Jul.
No abstract available

Keywords: COVID-19; SARS-CoV-2; calcineurin inhibitors; everolimus; immunosuppression; mycophenolate; pneumonia; tacrolimus; transplantation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest JC has received lecture fees from Chiesi, Astellas and Novartis. Advisory to Chiesi. MR-P has received lecture fees from Astellas, Novartis and Intercept Pharma. MS has received lecture fees from Astellas, Novartis, and Chiesi. Advisory to Jazz and Novartis. JP has received lecture fees by Astellas, Chiesi, and Gilead. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

References

    1. Webb G.J., Moon A.M., Barnes E., Barritt A.S., Marjot T. Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients. J Hepatol. 2021;75:226–228. - PMC - PubMed
    1. Colmenero J., Rodríguez-Perálvarez M., Salcedo M., Arias-Milla A., Munoz-Serrano A., Graus J., et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2021;74:148–155. - PMC - PubMed
    1. Webb G.J., Marjot T., Cook J.A., Aloman C., Armstrong M.J., Brenner E.J., et al. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. Lancet Gastroenterol Hepatol. 2020;5:1008–1016. - PMC - PubMed
    1. Hosey M.M., Needham D.M. Survivorship after COVID-19 ICU stay. Nat Rev Dis Primers. 2020;6:60. - PMC - PubMed
    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. - PMC - PubMed

Substances